Indrayani Biotech share price
BSE: 526445Agricultural Food & other ProductsSmall Cap
Last close ₹8.34down ₹0.43 (4.90%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹8.77.
52-week range of traded prices to 8 Oct 2026
₹6.10Low, 19 Mar 2026₹16.47High, 15 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹38 Cr3,322nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Owners' profit not stated
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 22 Sep 2026
- 0.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 8 Oct 2026
- 1.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 22 Sep 2026
- 1.26
- Volume, BSEVolume. Shares traded on the last trading day.
- 19,910
Results
Standalone, as consolidated accounts are on record for only 6 of the last ten years; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 8 Oct
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹4.15 Crup 1.80%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹0.15 Crup 517.45%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 3.5%
Revenue by year
Peak revenue ₹74 Cr, year to Mar 2023
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 3 of the 10 years shown
| ₹ crore | Sep 2024Filed 15 Nov | Dec 2024Filed 27 Feb | Mar 2025Filed 14 Jun | Jun 2025Filed 15 Aug | Sep 2025Filed 19 Dec | Dec 2025Filed 26 Feb | Mar 2026Filed 22 Sep | Jun 2026Filed 8 Oct |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.51 | 8.19 | 9.28 | 6.69 | 5.93 | 5.20 | 4.08 | 4.15 |
| Net profit | 0.10 | 0.11 | 0.20 | 0.13 | 0.47 | 0.08 | 0.02 | 0.15 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 1.0% | 1.3% | 2.2% | 1.9% | 7.9% | 1.5% | 0.6% | 3.5% |
Standalone. The last eight quarters. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, FOOD AND BEVERAGES, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, P/E: a quarter's profit for shareholders does not agree with its own earnings per share. Dividend yield is not shown: no dividend in the years on record.PE ratio and valuation history
Price to bookPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
At or below today's level on 5% of 1,101 trading days over the last 5 years.
LowestHighest
Its median3.4Industry median1.8
EV to EBITDAEnterprise value to EBITDA. Market cap plus borrowings less cash and bank balances, divided by operating profit before depreciation (revenue less operating expenses, without other income and one-off items) over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly): what the whole business costs against the profit its operations make. Lease liabilities are not counted: the results filings do not state them.18.2
At or below today's level on 44% of 1,099 trading days over the last 5 years.
LowestHighest
Its median23.2Industry median12.4
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −49.3% | −51.6% | +4.8% | 0.0% |
| 3 years | −49.6% | −53.0% | +7.1% | 0.0% |
| 5 years | +2.6% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1, 3 and 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Peers and competitors
Other Agricultural Products, 93 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Indrayani Biotech in market cap. 1 company in the table last traded before then: its row is priced on its last trade.
Indrayani Biotech is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Unique OrganicsUNIQUEO | 49 | 6.0 | 1.2 | 4.9 | −25.5% | −11.3% | 22.0% | 17.8% | 1.59% |
 Dhanlaxmi Crop ScienceDHANLAXMI | 44 | – | 1.0 | 51.6 | – | – | −1.1% | – | 0.00% |
 Annvrridhhi VenturesANVRDHI | 43 | 51.6 | 2.3 | 36.3 | +50.8% | +137.4% | 5.7% | 4.7% | 0.00% |
 Dhanwel Hybrid SeedsDHANWEL | 38 | – | – | – | – | – | – | – | 0.00% |
 Vishwas Agri SeedsVISHWAS | 37 | 17.4 | 0.7 | – | +11.0% | −68.1% | 4.2% | – | 0.00% |
 Times Green Energy (India)TIMESGREEN | 36 | 161.2 | 0.8 | – | −44.9% | −40.9% | 0.6% | – | 0.00% |
 Spright AgroSPRIGHT | 35 | – | 0.3 | – | −75.3% | −196.1% | −17.5% | −20.1% | 0.00% |
 RKD Agri & RetailRKDAGRRTL | 34 | – | 9.0 | – | −21.9% | – | −15.6% | −11.1% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
21 Oct · Update On Income Tax Recovery Proceeding
Sep 2026
30 Sep · Sale Of Shares Of Subsidiary Company Under Regulation 30 Of SEBI LODR 2015
30 Sep · Board meeting
Meeting on 7 Oct 2026: quarterly results
Indrayani Biotech share price by year
Each calendar year to 2025.Indrayani Biotech share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 11.31 | −68.8% | 36.43 | 11.30 |
| 2024 | 36.24 | −42.6% | 89.40 | 35.17 |
| 2023 | 63.17 | −16.8% | 82.10 | 49.47 |
| 2022 | 75.95 | +183.9% | 112.25 | 19.05 |
| 2021 | 26.75 | +249.7% | 28.75 | 4.86 |
| 2020 | 7.65 | +16.4% | 9.24 | 6.49 |
| 2019 | 6.57 | −17.9% | 7.60 | 4.75 |
| 2018 | 8.00 | +128.6% | 8.16 | 3.17 |
| 2017 | 3.50 | −57.2% | 9.11 | 3.43 |
| 2016 | 8.17 | −15.8% | 10.22 | 5.08 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 8.77 | 9.14 | 8.34 | 8.34 | 8.37 | 19,910 |
| 22 Oct 2026 | 8.50 | 9.09 | 8.50 | 8.77 | 8.76 | 36,635 |
| 21 Oct 2026 | 8.60 | 8.68 | 8.41 | 8.68 | 8.60 | 91,451 |
| 19 Oct 2026 | 8.06 | 8.40 | 8.06 | 8.27 | 8.25 | 16,151 |
| 16 Oct 2026 | 7.87 | 8.20 | 7.66 | 8.15 | 7.93 | 43,917 |
| 15 Oct 2026 | 8.39 | 8.40 | 7.98 | 8.02 | 8.01 | 97,983 |
| 14 Oct 2026 | 8.25 | 8.88 | 8.07 | 8.39 | 8.13 | 1,14,332 |
| 13 Oct 2026 | 9.00 | 9.00 | 8.31 | 8.49 | 8.42 | 41,195 |
| 12 Oct 2026 | 8.72 | 9.01 | 8.69 | 8.69 | 8.71 | 1,16,046 |
| 9 Oct 2026 | 9.70 | 9.70 | 9.11 | 9.14 | 9.14 | 36,456 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Rights issue and open offer history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 28 Apr 2026 | Rights issue | – | Shareholders were offered new shares. Noted, not adjusted for. |
| 24 Sep 2010 | Scheme of arrangement | – | A scheme of arrangement is a court-approved plan that merges, splits off or reorganises parts of a company. One took effect here and the price moved by a fifth or more between two trading sessions. What shareholders received is not on record, so earlier prices are not shown. |
Where an event has no factor that can be worked out, the chart leaves out the closes before it. Any other event is noted and not adjusted for.
Company details
- Legal name
- Indrayani Biotech Ltd.
- BSE code
- 526445
- ISIN
- INE007C01021
- Industry
- Agricultural Food & other Products
- Listed
- May 1994
- Face value
- ₹10
- CIN
- L40100TN1992PLC129301
- Corporate identity number, the registrar of companies' code for it